During the past decade, Universitätsklinikum Erlangen; Medizinische Klinik 4; Nephrologie und Hypertensiologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Erlangen; Medizinische Klinik 4; Nephrologie und Hypertensiologie" are "Chronic Renal Anemia" (1 trials) and "Cytomegalovirus Infections" (1 trials). Many other conditions were trialed in "Universitätsklinikum Erlangen; Medizinische Klinik 4; Nephrologie und Hypertensiologie" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Erlangen; Medizinische Klinik 4; Nephrologie und Hypertensiologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Darbepoetin Alfa" (1 trials), "Epoetin Alfa" (1 trials), "Epoetin Beta" (1 trials), "Valganciclovir" (1 trials) and "methoxy polyethylene glycol-epoetin beta" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Erlangen; Medizinische Klinik 4; Nephrologie und Hypertensiologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Erlangen; Medizinische Klinik 4; Nephrologie und Hypertensiologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Universitätsklinikum Erlangen; Medizinische Klinik 4; Nephrologie und Hypertensiologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Erlangen; Medizinische Klinik 4; Nephrologie und Hypertensiologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".